Revolution Medicines
Price & Volume
Stats
See more52W Range | $29.17-$62.40 |
Market Cap | $7.4B |
Shares Short | 18M |
Financials
See moreRevenue (12 Mos) | $742,000 |
Revenue Growth (YoY) | -95.2% |
Gross Profit (12 Mos) | -$679.9M |
Diluted EPS | -$4.01 |
News
See moreYahoo Finance • yesterday
Revolution Medicines secures $2 billion funding deal with Royalty Pharma
Yahoo Finance • 2 days ago
Sector Update: Health Care Stocks Mixed in Afternoon Trading
Yahoo Finance • 2 days ago
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer with KRAS G12 Mutations
Yahoo Finance • 7 days ago
Revolution Medicines director Weber resigns ahead of annual meeting
About
CEO | Dr. Mark A. Goldsmith Ph.D. |
Address | 700 Saginaw Drive, Redwood City, CA, United States, 94063 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 616 |
